TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Sensitivity of 68Ga-PSMA-11 PET/CT imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the receiver operator characteristics curve (AUROC) for detecting nocturnal level 1 hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall Composite of Diet Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in anxiety sensitivity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hazardous drinking patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cosmetic Outcomes (BREAST-Q questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cosmetic Outcomes (Harvard Breast Cosmesis Grading Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perioperative complications (CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Homeostatic model assessment of insulin resistance (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of substance use episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of substance use episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Recidivism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak PNIF response to incremental doses of Oxymetazoline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of the Intervention Measure (AIM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility measurement from Parents of Children using the Gus gear vest device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction survey from Parents of Children using the Gus gear vest device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction survey from nurses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of surgeries with full sealant coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline in staff attitude towards the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in tolerability (Do participants experience symptoms of simulator sickness?)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of the intervention: System Usability Scale (SUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Procedure time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total number of mature (MII) oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in patellar tendon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Weight Loss at Week 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of postpartum family planning at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of postpartum family planning at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fugl-Meyer Assessment score of Upper Extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Silicone oil-related ocular complication
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Infusional Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration in plasma of dabigatran before administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration in plasma of dabigatran after administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Muscular Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Functional Limitations and Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of Cognitive Status
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: rate of patients developing atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 10 sit-to-stand test in seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip strength in kilograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-meter walk test in metre per second
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KDQOLTM(Kidney Disease Quality of Life short Form) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Binocular corrected distance visual acuity (CDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary patency of the AVF at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Neutrophil-Lymphocyte Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Carotid Plaque Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Access site related vascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Symptomatic Relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Motor function as measured by Fugl-Meyer Assessment Scale (FMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Entresto
Endpoint domain: Adverse events/effects
Primary endpoint: Emergency Department readmission rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Revascularization to mTICI 2b or 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Residual Femur motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skin strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Potential injury incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Contrast Volume after Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Block and Box Test (BBT) of Motor functional test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG alpha band and Beta band
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Balance and gait performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Oral Squamous Cell Carcinoma (OSCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in the occurrence of macroscopic TWA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of EIM+
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of EIM+
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain level perceived by the patient
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of breaths in predefined zones of ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of time in predefined zones of ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: level of flow rate proximal to the patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Framingham Risk Score for Cardiovascular Disease Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in leakage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of participant report vs EEG assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of EEG recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of gallium Ga 68 gozetotide
Endpoint domain: Adverse events/effects
Primary endpoint: muscle activation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG signal amplitude and time profile across the gait cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade of TIL in melanoma biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composition of TILs within melanoma biopsy specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Validation of rs-fMRI mapping of language and motor areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent change in microvascular function/activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fitbit adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficacy of venetoclax with irinotecan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competency of nurses
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Self-efficacy of nurses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pharmacokinetic profile of Hemay005
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak postprandial interstitial glucose concentration (C-Max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: response prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with abnormal troponin I laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of participants with new electrocardiogram (ECG) abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DASH scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical and subclinical macular oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aggregation capacity of platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Length of time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Identification of biomarkers of response to anti6PD1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from initial dosing to 24 hours (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drug optimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcriptomic profile change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke/paradoxical embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain change at 1 month
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neuropathic Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parasite multiplication rate (PMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from Baseline muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pre- and post-systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pre and post weight measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre- and post- anxiety and depression levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pre and post complete blood count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Back functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The innominate angle tilt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of participants with triggered/positive laryngeal adduction response (LAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median scores on the Penetration-Aspiration Scale (PAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary flow (mL/min) in the LAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regulatory Emotional Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive Affect and Negative Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement of IBS global symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Manchester-Oxford Foot Questionnaire (MOXFQ) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to radiological diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Neurobehavioral responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Respiratory failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to improvement and recovery (COVID-19 clinical severity score of 3 or lower)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average tumour dose (Gy) by SPECT/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of adverse event per patient per grade by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal medication usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maternal Lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: success rate of first attempt insertion of the LMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Success rate at first attempt to cannulate the radial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bucco-lingual bone width gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemotherapy-induced peripheral neuropathy (CIPN) symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of teenagers adopting health behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SOFA-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative patient reconvalescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative patient activity tracking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: level of serum leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Vaccine Response for Anti-glycoprotein E (gE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: QTc (Corrected QT interval)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pressure Ulcer occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) of HR19024
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracheal Intubation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary Infection Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Decrease in number of catheterizations per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease in number of fecal incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decrease in number of urge urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Parent firearm safety attitudes and behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of occurred adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Measured changes of Systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measured changes of Body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Lund-Kennedy nasal endoscopy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dual-Task Timed Up and Go Test (cognitive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-m Backward Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of injections of ICG
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Angiographic-MRI abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skills needed to self-administer epinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement properties of the French CIQoL-35
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of intra-abdominal adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: death for any cause
Endpoint domain: Mortality/survival
Primary endpoint: hospitalization for any cause
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: sternal instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Natural killer (NK) cell killing activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ALS Specific QOL Short Form Quality of Life (ALSSQOL-SF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: World Health Organization Quality of Life (Brief) WHO-QoL BREF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feasibility of the music VR program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tolerability of the music VR program
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of the music VR program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Participants Maintaining Clinical Remission Responder Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exocrine function of the pancreas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction rate of lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operation length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Short-term adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Long-term adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of mortality in physicians due to COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of infection in physicians due to COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: rhythmicity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of MUC1 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Skin-to-skin operative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Relationship of Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change of oxyhemoglobin concentration during gait tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of desoxyhemoglobin concentration during gait tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HF DPOAE measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall of precise information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recall of general information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning